Brian Robertson

 

The aim of our research is to understand the host-pathogen interactions underlying the complex biology of tuberculosis infection, and to exploit this understanding for development of improved tools for disease control. We are investigating different ways to deliver anti-TB drugs, the potential of anti-microbial peptides and host-directed therapies to improve TB treatment, and how we can measure the potential efficacy of novel vaccines more effectively in humans.